1. Home
  2. FIX vs BIIB Comparison

FIX vs BIIB Comparison

Compare FIX & BIIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comfort Systems USA Inc.

FIX

Comfort Systems USA Inc.

HOLD

Current Price

$1,017.04

Market Cap

29.2B

Sector

Industrials

ML Signal

HOLD

Logo Biogen Inc.

BIIB

Biogen Inc.

HOLD

Current Price

$181.36

Market Cap

24.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIX
BIIB
Founded
1917
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.2B
24.2B
IPO Year
1997
1991

Fundamental Metrics

Financial Performance
Metric
FIX
BIIB
Price
$1,017.04
$181.36
Analyst Decision
Strong Buy
Buy
Analyst Count
4
23
Target Price
$955.67
$176.48
AVG Volume (30 Days)
540.8K
1.9M
Earning Date
10-23-2025
10-30-2025
Dividend Yield
0.24%
N/A
EPS Growth
80.49
N/A
EPS
23.59
10.97
Revenue
$8,323,378,000.00
$10,065,900,000.00
Revenue This Year
$25.54
$3.61
Revenue Next Year
$15.00
N/A
P/E Ratio
$42.46
$16.52
Revenue Growth
27.71
4.77
52 Week Low
$276.44
$110.04
52 Week High
$1,020.26
$185.17

Technical Indicators

Market Signals
Indicator
FIX
BIIB
Relative Strength Index (RSI) 62.92 72.56
Support Level $910.05 $174.53
Resistance Level $988.68 $183.15
Average True Range (ATR) 44.38 5.10
MACD 4.94 0.01
Stochastic Oscillator 89.72 82.93

Price Performance

Historical Comparison
FIX
BIIB

About FIX Comfort Systems USA Inc.

Comfort Systems USA Inc provides comprehensive mechanical contracting services, including heating, ventilation, & air conditioning, or HVAC; plumbing; piping & controls; construction; and other electrical components. Projects are mainly for commercial, industrial, & institutional buildings, & tend to be geared toward HVAC. Revenue is roughly split between installation services for newly constructed facilities & maintenance services for existing buildings. The company installs & repairs products and systems throughout the United States. It operates in two segments, Mechanical services & Electrical services, the majority is from the Mechanical services segment.

About BIIB Biogen Inc.

Biogen is an established biopharmaceutical company focused on treatments for neurological diseases and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 45% of total revenue in 2024. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (18% of total in 2024), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).

Share on Social Networks: